BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 3456864)

  • 21. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
    Aljurf M; Cornbleet PJ; Michel F
    Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
    Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
    Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous mouse erythrocyte-rosette formation: correlation with surface immunoglobulin phenotype in hairy-cell leukaemia.
    Burns GF; Cawley JC
    Clin Exp Immunol; 1980 Jan; 39(1):83-9. PubMed ID: 6966990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-surface-marker phenotyping in patients with leukemic non-Hodgkin lymphomas (NHL) of low and intermediate malignancy.
    Herrmann F; Wirthmüller R
    Immunobiology; 1982 Oct; 163(1):77-94. PubMed ID: 7173978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic modulation of chronic lymphocytic, prolymphocytic, and lymphoplasmacytic leukemia cells by TPA: induction of TRAP isoenzyme 5 and HD6 (CD22) antigen and enhancement of IgM messenger RNA.
    Thiel E; Pachmann K; Dörken B; Gaedicke G; Ziegler-Heitbrock HW
    Blood Cells; 1987; 12(2):365-83. PubMed ID: 3476168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hematomorphological differential diagnosis of small cell lymphoma. What is the atypical chronic lymphadenosis?].
    Theml H; Dietzfelbinger H; Burger-Schüler A; Kaboth W; Rastetter I; Begemann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):583-600. PubMed ID: 6162727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
    Gazitt Y; Polliack A
    Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic lymphoid leukemias: recent advances in biology and therapy.
    Foon KA
    Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
    Sokol L; Agosti SJ
    Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.
    Batata A; Shen B
    Cancer; 1992 Nov; 70(10):2436-43. PubMed ID: 1384948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal.
    Melo JV; Catovsky D; Galton DA
    Blood Cells; 1987; 12(2):339-53. PubMed ID: 3476167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia.
    Aisenberg AC; Wilkes BM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4810-3. PubMed ID: 6975164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hairy cell leukemia and other "hairy-cell" lymphoproliferative disorders (LPD-HC): the significance of morphologic, histologic and immunologic studies.
    Yavorkovsky LL; Gipsh NM; Karminskaya NM; Udris OYu ; Nikulshin SV; Yavorkovsky LI
    Neoplasma; 1990; 37(4):439-44. PubMed ID: 2234204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia].
    Guillaume N; Alimardani G; Capiod JC; Claisse JF
    Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between different cell surface markers in chronic lymphocytic leukemia.
    Potomski J; Harłozińska A; Becker M; Noworolska A
    Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adhesion molecules in B-chronic lymphoproliferative disorders.
    Angelopoulou MK; Kontopidou FN; Pangalis GA
    Semin Hematol; 1999 Apr; 36(2):178-97. PubMed ID: 10319387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the CD11c antigen in B-cell chronic lymphoproliferative disorders.
    Marotta G; Raspadori D; Sestigiani C; Scalia G; Bigazzi C; Lauria F
    Leuk Lymphoma; 2000 Mar; 37(1-2):145-9. PubMed ID: 10721778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The diagnostic value of T- and B-rosette formation and the unspecific acid esterase in the differential diagnosis of acute and chronic leukemia].
    Gudat F; Albrecht R; Kasper M; Krey G; Dürmüller U; Heitz P; Ludwig C; Christen C; Obrecht JP
    Schweiz Med Wochenschr; 1981 Sep; 111(36):1325-30. PubMed ID: 6946556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosetting index (E rosettes/mouse rosettes): a simple diagnostic and prognostic value in CLL.
    Berrebi A; Talmor M; Kluger Y; Shtalrid M; Vorst J
    Haematologia (Budap); 1984; 17(4):427-32. PubMed ID: 6532911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.